The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2, open-label study of neoadjuvant chemotherapy plus tislelizumab followed by radiotherapy-based, bladder-preserving treatment for high risk/locally advanced muscle invasive urothelial bladder cancer (HOPE-02).
 
Feng Wen
No Relationships to Disclose
 
Tianhai Lin
No Relationships to Disclose
 
Peng Zhang
No Relationships to Disclose
 
Ping Tan
No Relationships to Disclose
 
Xiaonan Zheng
No Relationships to Disclose
 
Yali Shen
No Relationships to Disclose